Usa Maryland Virus reports Usa Maryland

Curing HIV?

Reading now: 486

AGT CEO Jeff Galvan American Gene Technologies prepares for Phase 2 trials of a treatment that may eliminate HIV from the body DAVID TAFFET | Senior Staff Maryland-based gene therapy company has completed Phase 1 trials on a cure for HIV/AIDS and is preparing to submit protocols to the Food and Drug Administration for Phase 2.

According to American Gene Technologies, “The trial hit two major benchmarks — proving that its treatment is safe and durable.” “We want to use cutting-edge gene therapies to find cures, not treatments,” said AGT CEO Jeff Galvin in a press release. “We want to disrupt the pharmaceutical industry and replace existing, expensive Big Pharma symptomatic treatments.

We want to revolutionize healthcare.” When a T-cell product that has been taken from a person infected with HIV is modified with the company’s AGT 103, the trial showed it was tolerated well and that these enhanced T-cells persist and are ready to respond to the HIV virus.

The website is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News